Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cyanconnode, Rosslyn Data rise on contract wins

Mon, 22nd Aug 2022 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cyanconnode Holdings PLC, up 29% at 19.00 pence, 12-month range 11.00p-29.85p. The narrowband radio frequency smart mesh networks firm says Indian subsidiary has received its largest-ever order. CyanConnode India Pvt Ltd has received an order from Genus Power Infrastructures Ltd for one million Omnimesh modules, together with advanced metering infrastructure, standards-based hardware, Omnimesh head-end software, perpetual license and a support and maintenance contract. The support and maintenance contract runs for eight years, starting upon completion of the installation phase.

----------

Rosslyn Data Technologies PLC, up 12% at 2.36p, 12-month range 1.50p-5.98p. The data management and analytics service provider wins first enterprise customer through partnership with indirect procurement service provider Chain IQ Group AG. Says initial contract is "of relatively small monetary value" but expects further contracts to come from partnership. Chief Executive Paul Watts says deal highlights value of partnership with Chain IQ.

----------

Open Orphan PLC, up 5.9% at 11.91p, 12-month range 10.00p-27.75p. The pharmaceutical services firm says subsidiary hVIVO Ltd has won a GBP10.4 million contract. Open Orphan says the contract has been signed with an "existing top five global pharmaceutical client". This is the third human challenge contract signed with the client, it adds.

----------

AIM - LOSERS

----------

Artemis Resources Ltd, down 11% at 2.05p, 12-month range 1.44p-5.00p. The miner says no significant nickel or copper results are found in laboratory analyses of samples from the first drill hole at the Osborne nickel prospect. Further, in a separate statement regarding its Greater Carlow project, holes ARC395 and ARC396 "did not return any significant mineralisation, in line with the offset of the lodes already discovered by holes ARC403 and ARC404," the Perth-based miner with gold, copper and cobalt projects in Australia adds.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
9 Mar 2021 14:31

IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics

IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics

Read more
9 Mar 2021 11:38

Open Orphan subsidiary awarded contract with Oxford BioTherapeutics

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Tuesday that its subsidiary Venn Life Sciences had been awarded a contract for a study with clinical-stage oncology company Oxford BioTherapeutics.

Read more
17 Feb 2021 13:48

IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval

IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval

Read more
3 Feb 2021 16:28

Open Orphan opens new quarantine clinic in Whitechapel

(Sharecast News) - Pharmaceutical services contract research organisation (CRO) Open Orphan has opened a new quarantine clinic in east London, it announced on Wednesday.

Read more
3 Feb 2021 11:55

IN BRIEF: Open Orphan Launches New Quarantine Clinic In London

IN BRIEF: Open Orphan Launches New Quarantine Clinic In London

Read more
1 Feb 2021 13:20

Open Orphan renews contract with Carna Biosciences

(Sharecast News) - Pharmaceutical services clinical research organisation Open Orphan announced a further contract renewal with Carna Biosciences on Monday, extending its integrated drug development consultancy services with Open Orphan subsidiary Venn Life Sciences.

Read more
1 Feb 2021 11:54

IN BRIEF: Open Orphan Inks Contract Renewal With Carna Biosciences

IN BRIEF: Open Orphan Inks Contract Renewal With Carna Biosciences

Read more
20 Jan 2021 21:16

IN BRIEF: Open Orphan Opens Two New Volunteer Recruitment Centres

IN BRIEF: Open Orphan Opens Two New Volunteer Recruitment Centres

Read more
11 Jan 2021 15:56

Open Orphan confirms first volunteer dosing of needle-free Covid vaccine

(Sharecast News) - Specialist pharmaceutical services contract research organisation Open Orphan announced on Monday that the first volunteer had been dosed with the Codagenix needle-free intranasal Covid-19 vaccine, 'COVI-VAC'.

Read more
11 Jan 2021 11:45

Open Orphan Doses First Volunteer In Needle Free Covid Vaccine Trial

Open Orphan Doses First Volunteer In Needle Free Covid Vaccine Trial

Read more
6 Jan 2021 14:37

IN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma Client

IN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma Client

Read more
23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Read more
22 Dec 2020 14:26

IN BRIEF: Open Orphan Pens Contract Extension With Major Client

IN BRIEF: Open Orphan Pens Contract Extension With Major Client

Read more
22 Dec 2020 10:44

Open Orphan renews contract with top-3 pharma client

(Sharecast News) - Pharmaceutical services contract research organisation Open Orphan announced a contract renewal on Tuesday, extending its consultancy services with an unnamed "major top-three global" pharmaceutical client to December 2021.

Read more
14 Dec 2020 22:04

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.